ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.500
0.00 (0.00%)
Apr 24, 2026, 5:07 PM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €40.28 million as of April 24, 2026. Its market cap has decreased by -54.95% in one year.
Market Cap
40.28M
Enterprise Value
42.05M
Revenue
6.23M
Ranking
n/a
PE Ratio
86.94
Stock Price
€2.50
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 40.28M, an increase of 1,506.19%. That is a compound annual growth rate of 11.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 40.28M | -16.67% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 98.73B |
| EssilorLuxottica Société anonyme | 88.52B |
| Sartorius Stedim Biotech | 15.36B |
| Ipsen | 13.59B |
| Klea Holding | 53.97M |
| Fermentalg | 51.49M |
| THX Pharma Société Anonyme | 46.29M |
| S.M.A.I.O | 43.03M |